Positive news on COVID vaccines weighs against concerns over new variants
Positive news on COVID vaccines weighs against concerns over new variants MarketWatch 2/25/2021 CORONAVIRUS UPDATE The COVID-19 vaccine developed by Pfizer Inc. and German partner BioNTech SE has proved to be as effective in the real world as it was in clinical trials in the first major study of the two-dose regimen involving 1.2 million people in Israel. The data was peer-reviewed and published in the prestigious New England Journal of Medicine on Wednesday, and found the vaccine cut symptomatic cases of COVID by 94% across all age groups. It also reduced severe illness by 92%, according t...